Fabneu 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing uric acid levels in the blood. Elevated uric acid can lead to the formation of painful urate crystals in joints, causing gout attacks. Fabneu 40 is prescribed to prevent gout flares and to promote the dissolution of urate crystals, improving joint function and reducing inflammation. It is typically recommended for patients who have not responded well to other urate-lowering therapies or who are intolerant to allopurinol. The tablet should be taken once daily, with or without food, as directed by a healthcare professional. Patients are advised to maintain adequate hydration to help prevent kidney stones. Common side effects may include nausea, rash, and liver enzyme abnormalities, so regular monitoring of liver function is important during treatment. Fabneu 40 is not suitable for patients with severe liver impairment or those with a history of cardiovascular disease without medical supervision. Always consult a healthcare provider before starting or stopping this medication to ensure safe and effective use.

Dosage & How to Use